Bone Augmentation of Atrophic Alveolar Ridges Using a Synthetic Bone Substitute With Mesenchymal Stem Cells: A Randomized, Controlled Clinical Trial
Clinical Oral Implants Research · 2025-11 · 36 (11) · 1498-1514
DOI: 10.1111/clr.70025 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Oral Implants Research, online erschienen am 22.08.2025. Verfasst von Mariano Sanz und 19 weiteren Autor:innen. Beteiligte Einrichtung: Etiology and Therapy of Periodontal and Periimplant Diseases (ETEP) Research Group, Faculty of Odontology, Complutense University, Madrid, Spain. Hauptthemen laut MEDLINE: Alveolar Ridge Augmentation, Mesenchymal Stem Cell Transplantation, Bone Substitutes, Alveolar Bone Loss. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Union, European Commission.
Abstract (Originalsprache)
Objectives
To assess the efficacy and safety of a cell‐based therapy for 3D bone augmentation of severe alveolar bone defects prior to dental implant placement. Materials and Methods A Phase 2 randomized controlled clinical trial evaluated the safety and efficacy of a cell therapy using expanded autologous iliac crest‐derived mesenchymal cells seeded on a synthetic bioabsorbable bone substitute covered with a non‐resorbable membrane. The control group received an autogenous bone block graft. After 5 months, CBCT scans were compared to measure the bone volume changes achieved after the regenerative surgery. Subsequently, dental implants were placed in the regenerated areas.
Results
A total of 48 patients were included and randomized (36 patients in the test group and 12 in the control group). However, seven patients did not reach the minimum required number of expanded MSCs and were therefore unable to be treated. The tested intervention demonstrated significantly greater gains in bone volume, with a mean difference of 480.01 mm 3 ( p = 0.032). Similarly, the mean change in bone crest volume from baseline to 5 months was notably higher in the test group (1066.91 mm 3 ) compared to the control group (586.9 mm 3 ). Adverse reactions and patient morbidity were minor in both groups. Implants were placed on the regenerated bone, and all were integrated successfully in both groups.
Conclusions
The cell‐based therapy resulted in significant changes in bone volume compared to the control treatment, enabling dental implants in all patients. The procedure was associated with minimal adverse effects and patient morbidity. Trial Registration ClinicalTrials.gov : NCT03373052, NCT04297813
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Etiology and Therapy of Periodontal and Periimplant Diseases (ETEP) Research Group, Faculty of Odontology, Complutense University, Madrid, Spain.
- Center of Translational Oral Research - Tissue Engineering, Department of Clinical Dentistry, Faculty of Medicine, University of Bergen (UiB), Bergen, Norway.
- Department of Clinical Science, Faculty of Medicine, University of Bergen (UiB), Bergen, Norway.
- Department of Clinical Science, Hematology Section, Haukeland University Hospital (HUH), Bergen, Norway.
- CHU Nantes, UIC 11 Odontologie, Université de Nantes, Nantes, France.
- Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Universitat Internacional de Catalunya (UIC), Barcelona, Spain.
ORCID-Profile: Mariano Sanz, Cecilie Gjerde, Bjørn Tore Gjertsen, Alberto Ortiz-Vigón, Nerea Sanchez, Alain Hoornaert, Jordi Caballe-Serrano, Maria Giralt-Hernando, Frederick Gaultier, Else Marie Pinholt, Samih Mohamed-Ahmed, Xieqi Shi, Tie-Jun Shi, Pierre Layrolle, Kamal Mustafa
Förderung
- European Union
- European Commission
Zitieren
APA
Sanz, M., Gjerde, C., Gjertsen, B. T., Ortiz-Vigón, A., Sanchez, N., Hoornaert, A., Caballe-Serrano, J., Giralt-Hernando, M., Gaultier, F., Reinald, N., Pinholt, E. M., Rojewski, M., Rouard, H., Chevallier, N., Mohamed-Ahmed, S., Shi, X., Shi, T. J., Schrezenmeier, H., Layrolle, P., & Mustafa, K. (2025). Bone Augmentation of Atrophic Alveolar Ridges Using a Synthetic Bone Substitute With Mesenchymal Stem Cells: A Randomized, Controlled Clinical Trial. Clinical Oral Implants Research, 36(11), 1498-1514. https://doi.org/10.1111/clr.70025
Vancouver
Sanz M, Gjerde C, Gjertsen BT, Ortiz-Vigón A, Sanchez N, Hoornaert A, et al. Bone Augmentation of Atrophic Alveolar Ridges Using a Synthetic Bone Substitute With Mesenchymal Stem Cells: A Randomized, Controlled Clinical Trial. Clinical Oral Implants Research. 2025;36(11):1498-1514. doi:10.1111/clr.70025
BibTeX
@article{Sanz2025,
author = {Sanz, Mariano and Gjerde, Cecilie and Gjertsen, Bjørn Tore and Ortiz-Vigón, Alberto and Sanchez, Nerea and Hoornaert, Alain and Caballe-Serrano, Jordi and Giralt-Hernando, Maria and Gaultier, Frederick and Reinald, Nicoleta and Pinholt, Else Marie and Rojewski, Markus and Rouard, Helen and Chevallier, Nathalie and Mohamed-Ahmed, Samih and Shi, Xieqi and Shi, Tie-Jun and Schrezenmeier, Hubert and Layrolle, Pierre and Mustafa, Kamal},
title = {Bone Augmentation of Atrophic Alveolar Ridges Using a Synthetic Bone Substitute With Mesenchymal Stem Cells: A Randomized, Controlled Clinical Trial},
journal = {Clinical Oral Implants Research},
year = {2025},
volume = {36},
number = {11},
pages = {1498--1514},
doi = {10.1111/clr.70025}
}
EUVIMED